Emerging Biomarker-Guided Therapies in Prostate Cancer.

ABSTRACT: Prostate cancer remains one of the leading causes of cancer death in men worldwide. In the past decade, several new treatments for advanced prostate cancer have been approved. With a wide variety of available drugs, including cytotoxic agents, androgen receptor axis-targeted therapies, and alpha-emitting radiation therapy, identifying their optimal sequencing remains a challenge. Progress in the understanding of the biology of prostate cancer has provided an opportunity for a more refined and personalized treatment selection process. With the advancement of molecular sequencing techniques, genomic precision through the identification of potential treatment targets and predictive biomarkers has been rapidly evolving. In this review, we discussed biomarker-driven treatments for advanced pros

SUBMITTER: Deluce JE 

PROVIDER: S-EPMC9319825 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature